National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Childhood Rhabdomyosarcoma Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 04/06/2009
Table 1. Definition of Terms

Term  Definition 
Favorable site Orbit; nonparameningeal head and neck; genitourinary excluding kidney, bladder, and prostate; biliary tract.
Unfavorable site Any site not considered favorable.
T1 Tumor confined to anatomic site of origin.
T2 Tumor extension and/or fixative to surrounding tissue.
a Tumor ≤5 cm in maximum diameter.
b Tumor >5 cm in maximum diameter.
N0 No clinical regional lymph node involvement.
N1 Clinical regional lymph node involvement.
NX Regional lymph nodes not examined; no information.
M0 No metastatic disease.
M1 Metastatic disease.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov